T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
NCT01142674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1650
Last updated 2019-07-08
Summary
The designed study follows up the retrospective previous one by the International T-cell Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project).
It is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed patients with the more frequent subtypes of Peripheral T-cell lymphoma (Peripheral T-cell lymphoma unspecified and Angioimmunoblastic T-cell lymphoma) and to better define clinical characteristics and outcome of the more uncommon subtypes
Conditions
- Lymphoma, T-Cell, Peripheral
Sponsors & Collaborators
-
Fondazione Italiana Linfomi - ETS
collaborator OTHER -
INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP
collaborator UNKNOWN -
Associazione Angela Serra per la ricerca sul cancro
lead OTHER
Principal Investigators
-
Massimo Federico, MD · Dip. Medicina Diagnostica - Università di Modena e Reggio Emilia, , Modena, IT
-
Julie M. Vose, MD · Nebraska Medical Center, Omaha, NE, USA
-
Emanuele Zucca, MD · IOSI/Oncology Institute of Southern Switzerland, Ospedale S. Giovanni - Bellinzona, CH
-
Joseph M Connors, MD · British Columbia Cancer Agency, Vancouver, CA
-
Steven M. Horwitz, MD · Memorial Sloan Kettering Cancer Center
-
Francine M. Foss, MD · Yale Cancer Center, New Haven, CT, USA
-
Pier Luigi Zinzani, MD · Istituto di Ematologia e Oncologia Medica "L. e A. Seragnoli", Policlinico Sant'Orsola, Bologna, IT
-
Silvia Montoto, MD · St. Bartholomew Hospital, London, UK
-
Aaron Polliack, MD · Sourasky Medical Center, Tel Aviv, IL
-
Stefano A. Pileri, MD · Università di Bologna, IT & Istituto Europeo di Oncologia, Milano, IT
-
Young H. Ko, MD · Samsung Medical Center, Seoul, KR
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2016-07-31
- Completion
- 2018-12-31
Countries
- United States
- Argentina
- Brazil
- Chile
- China
- France
- Israel
- Italy
- Slovakia
- South Korea
- Spain
- Switzerland
- United Kingdom
- Uruguay
Study Locations
More Related Trials
-
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916 ·Status: COMPLETED
-
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
NCT05237245 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 ·Status: RECRUITING ·Phase: NA
-
Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
NCT01679860 ·Status: COMPLETED ·Phase: PHASE2
-
Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas
NCT06089941 ·Status: ACTIVE_NOT_RECRUITING
-
Indolent Non Follicular Lymphomas Prognostic Project
NCT02904577 ·Status: COMPLETED
-
T-Cell Project: Epidemiologic Component
NCT00705809 ·Status: COMPLETED
-
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223 ·Status: COMPLETED
-
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
NCT06422247 ·Status: COMPLETED
-
Cohort of Peripheral T Cell Lymphoma
NCT02364466 ·Status: UNKNOWN
-
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 ·Status: COMPLETED
-
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
NCT03207789 ·Status: UNKNOWN
-
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
NCT00882011 ·Status: UNKNOWN
-
Italian Study of Patients With Lymphoma
NCT06814925 ·Status: RECRUITING
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT06008691 ·Status: RECRUITING
-
A Global Study of the PETAL Consortium
NCT06067347 ·Status: RECRUITING
-
Circulating Tumor DNA in Peripheral T-cell Lymphomas
NCT06362148 ·Status: ACTIVE_NOT_RECRUITING
-
International Extranodal NK/T-cell Lymphoma Project
NCT02386813 ·Status: COMPLETED
-
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
NCT01478269 ·Status: COMPLETED
-
Minimal Residual Disease in Peripheral T-cell Lymphoma
NCT03297697 ·Status: COMPLETED
-
CD34+ Selected ASCT for Aggressive Lymphomas
NCT02646098 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
NCT06024694 ·Status: ACTIVE_NOT_RECRUITING
-
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
NCT06585124 ·Status: RECRUITING
-
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT05182957 ·Status: RECRUITING ·Phase: PHASE2